UNSPSC 51342803: Delavirdine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C22H28N6O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DOL5F9JD3E, chemically known as piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1h-indol-2-yl)carbonyl)- but generally known as delavirdine, which bears US NIH Compound Identifier 5625. European Medicines Agency schedules Delavirdine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06949MIG.

UNSPSC 51342803 Delavirdine is a Commodity code that nominally identifies a specific antiretroviral pharmaceutical product; however, the recent state and local opportunities tagged under this code show little alignment with delavirdine procurement itself. Instead, the tagged records reflect broader pharmaceutical supply arrangements, including antibiotic warehousing through cooperative purchasing consortia and community health procurement of naloxone and drug deactivation systems. State and local health departments and county health agencies are the primary issuing bodies using this code space, though the opportunities suggest tagging inconsistency rather than established Delavirdine demand. The work being solicited includes pharmaceutical warehouse orders through piggyback agreements with established cooperative purchasing vehicles, as well as public health supply procurement for opioid overdose response and controlled-substance management.

Recent activity appears concentrated in the upper Midwest and Southeast. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 for antibiotic supply (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets) under Invitation for Bid 26482DPHPREPDB53392, with a 12-month initial term and renewal options for years 2 and 3. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to its community health building in Sanford, with electronic bid submission required and a two-year initial term plus one-year renewal option. The code shows limited recent open solicitation activity specifically for delavirdine; businesses should verify code assignment accuracy with issuing agencies before pursuing opportunities tagged under this Commodity designation.